Obesity Surgery

, Volume 20, Issue 7, pp 861–870

The Impact of Bariatric Surgery on Comorbidities and Medication Use Among Obese Patients

  • Pierre-Yves Crémieux
  • Severine Ledoux
  • Christine Clerici
  • Francois Cremieux
  • Marric Buessing
Clinical Research

Abstract

Background

The risks and benefits of bariatric surgery have rarely been evaluated in large multiyear patient samples. This study identifies the short- and long-term impact of bariatric surgery on comorbidities and medication use among obese patients.

Methods

A comprehensive analysis of 5,502 obese patients who underwent bariatric surgery was performed. Submissions of reimbursement claims, including diagnostics and medication use, were compared in the 90 days preceding the surgery and 30 up to 1,110 days following the surgery. Presurgery and postsurgery frequency counts were performed on diagnostics and medication use to identify trends.

Results

Among 5,502 patients, significant decreases in the prevalence of reported comorbidities were observed during the short-term postsurgery period and sustained for up to 3 years of follow-up. Compared to the presurgery period, significant decreases (p < 0.05) were observed after 3 years for total cardiovascular disorders (43.6% vs. 14.2%), diabetes mellitus (19.9% vs. 7.7%), chronic obstructive pulmonary disease and other respiratory conditions (57.7% vs. 16.2%), diseases of the musculoskeletal system and connective tissue (32.6% vs. 27.7%), and mental disorders (30.7% vs. 14.8%). Over the same period, the frequency of medication use decreased significantly for a number of conditions including infections, pain, respiratory, cardiovascular, gastroenterologic, lipidemic, and diabetic conditions. Anemia, however, increased from 3.8% to 9.9%, and use of nutritional supplements increased significantly.

Conclusion

Bariatric surgery was associated with significant reductions in reported claims for short- and long-term health outcomes and reduced medication use for major disease categories.

Keywords

Morbid obesity Quality of life Bariatric surgery Comorbidity Cardiovascular disease Diabetes mellitus 

References

  1. 1.
    Yanovski SZ, Yanovski JA. Obesity. N Engl J Med. 2002;346(8):591–602.CrossRefPubMedGoogle Scholar
  2. 2.
    NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956–61.Google Scholar
  3. 3.
    García-Zakzuk, B. 2005. Medical and Rx technologies—what’s in the pipeline. Society of Actuaries Record, vol. 31 (no. 2).Google Scholar
  4. 4.
    The American Society for Metabolic and Bariatric Surgery. 2009. Fact sheet: metabolic and bariatric surgery. http://www.asmbs.org/Newsite07/media/asmbs_fs_surgery.pdf. Accessed 16 November 2009.)
  5. 5.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMedGoogle Scholar
  6. 6.
    Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23. discussion 423–414.CrossRefPubMedGoogle Scholar
  7. 7.
    Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRefPubMedGoogle Scholar
  8. 8.
    Hodo DM, Waller JL, Martindale RG, et al. Medication use after bariatric surgery in a managed care cohort. Surg Obes Relat Dis. 2008;4:601–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Ninh T, Nguyen J, Varela E, et al. Reduction in prescription costs after laparoscopic gastric bypass. Am Surg. 2006;72:853–6.Google Scholar
  10. 10.
    Narbro K, Agren G, Jonsson E, et al. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med. 2002;162:2061–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Zingmond D, McGory M, Ko C. Hospitalization before and after gastric bypass surgery. JAMA. 2005;294:1918–24.CrossRefPubMedGoogle Scholar
  12. 12.
    Ukleja A, Stone RL. Medical and gastroenterologic management of the post-bariatric surgery patient. J Clin Gastroenterol. 2004;38:312–21.CrossRefPubMedGoogle Scholar
  13. 13.
    Ledoux S, Msika S, Moussa F, et al. Comparison of nutritional consequences of conventional therapy of obesity, adjustable gastric banding, and gastric bypass. Obes Surg. 2006;16:1041–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Segal JB, Clark JM, Shore AD, et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg. 2009;19:1646–56.CrossRefPubMedGoogle Scholar
  15. 15.
    Wilchesky M, Tamblyn R, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57(2):131–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Zizza CA, Herring AH, Stevens J, et al. Bariatric surgeries in North Carolina, 1990 to 2001: a gender comparison. Obes Res. 2003;11:1519–25.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2010

Authors and Affiliations

  • Pierre-Yves Crémieux
    • 3
  • Severine Ledoux
    • 1
  • Christine Clerici
    • 1
  • Francois Cremieux
    • 2
  • Marric Buessing
    • 3
  1. 1.Service des Explorations Fonctionelles—Hôpital Louis Mourier (AP-HP), Colombes and UFR de MédecineUniversité Paris 7ParisFrance
  2. 2.Hôpital Hotel-Dieu (AP-HP)ParisFrance
  3. 3.Analysis GroupBostonUSA

Personalised recommendations